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Help!
My dog was 
diagnosed 
with a liver 
problem!
Understanding common 
liver disorders in 
Yorkshire Terriers
 & other toy breeds
Brief Overview of 
Portosystemic Shunts
“ Congenital PSS and MVD 
are related genetic disorders causing 
malformation of the liver circulation.”
—Center
What is a Liver Shunt?
A liver shunt is a blood vessel that carries blood around 
the liver instead of through it. In some animals a liver 
shunt is a birth defect (“congenital portosystemic 
shunt”). In others, multiple small shunts (“acquired 
portosystemic shunts”) form because of severe liver 
disease such as cirrhosis. 
Why do animals with shunts have problems?
In the normal animal, food and other ingested 
materials are broken down or digested in the intestines 
and absorbed into the portal blood stream, where they 
are carried to the liver. The liver stores some of the food 
for energy, processes some of it into safe chemicals, and 
uses some of it to make proteins and other substances. 
Because the blood bypasses the liver in dogs with 
shunts, toxins may build up in the bloodstream or 
kidneys. Additionally, the animal lacks the necessary 
materials to give it a ready source of energy and to help 
it grow. 
What are the most common types of 
Portosystemic Shunts (PSS)?
There are a number of types of portosystemic shunts. 
Those present at birth are classified as “congenital.”
1. Single extrahepatic shunt: a single shunting vessel 
that is located outside the liver. This is the most 
common type of congenital shunt.
2. Single intrahepatic shunt: a single shunting 
vessel within the liver. These are congenital and 
most commonly seen in large-breed dogs.
 
3. Extrahepatic multiple acquired shunts: When 
blood pressure in the portal system becomes too 
high, multiple small blood vessels will open up to 
shunt blood around the liver. Multiple acquired shunts 
occur as a result of end stage liver disease (cirrhosis) 
and portal hypertension. These are not congenital and 
they are not surgically correctable.
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Microvascular Dysplasia and Congenital 
Portal Vein Hypoplasia
“PVH-MVD... when severe, can cause clinical signs and blood work changes similar to PSS, 
though usually to a lesser extent.”—Tobias
What is Microvascular Dysplasia?
Microvascular dysplasia (MVD) is a pathologic change 
in which the microscopic portal vessels of the liver are 
underdeveloped (“hypoplastic”); if severe, the associated 
liver tissue also appears shrunken or “atrophied”. These 
pathologic changes occur in animals that have congenital 
shunts. They are also seen in dogs with multiple acquired 
shunts that have cirrhosis or other causes of portal 
hypertension, which is known as non-cirrhotic portal 
hypertension. More often, however, MVD occurs in dogs 
that have no shunts, no portal hypertension, and often no 
clinical signs of illness. In those animals, the underlying 
condition is called congenital portal vein hypoplasia 
(PVH). Because this is the most common cause of 
MVD, many clinicians use the terms interchangeably. 
Unfortunately, PVH-MVD occurs in the same breeds 
that are commonly affected with congenital extrahepatic 
PSS (Maltese, Yorkies, Cairn terriers, etc.) and, when 
severe, can cause clinical signs and blood work changes 
similar to congenital PSS. PVH-MVD is congenital and 
is not surgically treatable.
Clearing up the confusion
Reading about congenital portal 
vein hypoplasia in scientific literature 
and on the internet can become 
confusing because this condition is 
known by several names, including 
“microvascular dysplasia” (MVD) and 
“hepatoportal microvascular dysplasia” 
(HMD). Because pathologists use the 
terms MVD or HMD to describe the 
same changes seen on liver biopsy 
for several conditions (including 
congenital portosystemic shunts), 
the World Small Animal Veterinary 
Association standardized the name 
to “primary congenital portal vein 
hypoplasia.” (Cullen 2009). Here we’ll use the term 
PVH-MVD to make sure everyone understands which 
condition is being discussed.
Understanding liver function
To understand the clinical problems associated with 
shunts and PVH-MVD, we first need to understand 
how the liver works. The liver performs an incredible 
number of functions to maintain health of animals, 
including filtering out toxins, manufacturing or storing 
sugar for energy, processing drugs and other chemicals, 
and making proteins. Most of the blood that is carried to 
the liver for these processes arrives via the portal vein, 
which drains the intestines, stomach, pancreas, and 
spleen. Within the liver, the portal vein branches into 
smaller and smaller vessels so that the blood can 
percolate throughout the tissues to the individual 
liver cells where all the work is performed. 
When portal blood is diverted around the liver 
or the microscopic vessels within the liver are 
underdeveloped or absent, the liver can no longer 
perform its normal functions efficiently. Clinical 
signs therefore result because the animal cannot 
clear out toxins or process drugs, lacks the building 
blocks for growth and repair, and develops side effects 
from excretion of toxins: ammonia forms ammonium 
biurate crystals (which look like spikey balls and are 
very irritating) and urate stones (which are not visible 
on plain x-rays), both of which predispose to urinary 
tract inflammation and infection.
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Clinical signs of dogs with congenital 
portosystemic shunts(PSS)
Animals with congenital PSS often present at a young 
age, unless the flow through the shunt is small or 
intermittent. Dogs with congenital PSS are often 
small in size and have and poor muscle mass and 
hair coat; breeders may note they are the “runts” of 
the litter. Most commonly these dogs have behavior 
changes such as weakness, a quiet demeanor, or dull 
attitude. Occasionally neurologic signs can be more 
severe, particularly if blood sugar is low or if excessive 
amounts of protein are consumed. In those instances, 
the dogs may pace, circle, act blind, press their heads 
against the wall, or even seizure. Because the liver is no 
longer efficiently processing ammonia from proteins, 
large amounts of the toxin are excreted into the kidneys 
and bladder where the ammonia can concentrate 
into spikey crystals (ammonium biurate crystals) or 
condense into stones (urate stones). Both conditions will 
result in urinary tract inflammation and infection. Dogs 
with congenital PSS may also urinate more frequently, 
and therefore drink more, because they lose the ability 
to concentrate their urine. Occasionally dogs will be 
nauseous, causing poor appetite, vomiting, or excessive 
salivation. Some dogs may even develop stomach ulcers. 
Neurologic and gastrointestinal signs can vary from day 
to day. (Figure 1)
Clinical signs of dogs with multiple acquired 
portosystemic shunts
Dogs with multiple acquired PSS are often middle aged 
or older, although puppies can develop the condition. 
Sometimes the owners may have noted a previous 
episode of severe illness or toxin ingestion associated 
with severe liver disease. If the bile system was affected 
by the initial problem, the dog may have a yellow tint 
to its skin, gums, and the whites of its eyes and its urine 
may be very dark. If the portal pressure is very high or 
the dog is not making enough protein, fluid will collect 
in the belly cavity (“ascites”). In dogs with severe liver 
disease, blood will not be able to clot effectively, and 





General Symptoms: smaller body stature, pediatric 
hypoglycemia (especially toy 
breeds and this can cause 
neurologic signs), failure to 




finicky eater, intermittent 
vomiting, diarrhea, episodic 
inappetence, anorexia, weight 
loss, gastrointestinal ulceration
Urinary Symptoms: urinary tract infections, cystitis/
urinary obstruction, excessive 






behavior changes, lethargy, 
sudden aggressiveness, 
depression, may seem less 
intelligent, dementia, stupor, 
pacing, circling, muscle tremors, 
head pressing, apparent 
blindness, seizures, coma
Other: jaundice (Acquired PSS), ascites 
(Acquired PSS), bleeding 
problems (Acquired PSS)
Figure 1. Table of clinical signs
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Clinical signs of dogs with PVH-MVD
Many dogs with PVH-MVD are “asymptomatic”; in fact, 
most Yorkies and Maltese that have this condition have 
no signs at all. However, some dogs do present with 
clinical signs that develop early or later in life. These 
dogs may either have a very underdeveloped liver or 
they may have another condition (e.g., epilepsy, toy 
breed hypoglycemia, hydrocephalus, inflammatory 
bowel disease, or behavioral issues) that is the actual 
cause of the signs. Unlike dogs with shunts, dogs with 
PVH-MVD rarely have neurologic signs from hepatic 
encephalopathy.
How we can tell if clinical signs are caused by PVH-MVD
We can’t be sure that clinical signs in dogs with increased 
bile acids and liver biopsy results consistent with PVH-
MVD are actually caused by the liver abnormality. If 
the biopsy changes are very severe, for instance, or the 
liver is inflamed or full of scar tissue, it is likely that 
clinical signs are related to those changes. However, if 
the biopsy changes are mild, the dog may actually have 
some other condition. We are especially suspicious that 
another condition is present if clinical signs do not go 
away with appropriate medical management.
What is hepatic encephalopathy?
Hepatic encephalopathy is a group of neurologic signs 
or behavior changes caused by severe liver disease. 
It has been recognized in animals with congenital or 
acquired PSS, end-stage liver disease, and congenital 
urea cycle enzyme deficiencies. Clinical signs include 
lethargy, dementia, stupor, and coma. Muscle tremors, 
motor abnormalities, and focal and generalized 
seizures have also been reported. The etiology of 
hepatic encephalopathy is probably dependent on 
several factors, including circulating toxins, alterations 
in amino acid concentrations, and increased cerebral 
sensitivity to drugs and toxins. A variety of toxins are 
implicated in the condition, with the most notable 
being ammonia. It is important to realize that some of 
these signs are seen with other conditions; if a dog has 
seizures but its liver function is normal or it does not 
respond to medical management of liver dysfunction, 
it is quite likely that the seizures are not caused by a 
shunt or PVH-MVD.
Conditions That Trigger HE
Hepatic Encephalopathy (HE) can be precipitated 
by high protein meals, intestinal hemorrhage (such 
as from parasites), transfusion with stored blood, 
infection, dehydration, constipation, and drugs such as 
anesthetics, analgesics, and tranquilizers. 
What are common laboratory changes found 
with congenital PSS?
A basic work-up for a dog suspected to have congenital 
PSS includes a complete blood count (CBC), 
chemistry analysis (biochemistry), urine analysis, and 
measurement of bile acids. Some veterinarians may 
also check protein C and ammonia concentrations; 
however, these tests require special processing to make 
sure they are accurate. Common laboratory changes 
include the following:
• Small red cells (“microcytosis”) on CBC, and 
sometimes increases in white blood cells.
• Decrease in total protein, albumin, BUN (blood 
urea nitrogen) on chemistries. Animals may also 
have increased liver enzymes or low cholesterol.
• Decreased urine specific gravity on urinalysis. 
Animals may also have ammonium biurate 
crystals or evidence of urinary tract infection 
(white blood cells, red blood cells, protein, and 
bacteria) in their urine sediment.
• Increases in fasting and fed serum bile acids. Bile 
acids are usually >70µmol/liter in dogs with PSS.
• Increased blood ammonia, especially 6 hours 
after a meal.
• Decreased protein C concentrations.
On plain abdominal x-rays, the liver is usually smaller 
than normal. Unfortunately, urate bladder stones may 
not show up on an x-ray, but they can be seen with 
ultrasound. Ultrasound can also be used to try and find 
the shunt and to rule out cirrhosis of the liver.
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If either sample  
is abnormal...the animal is 
considered to have some sort 




blame high bile 
acids on the 
type of meal 
used.”
—Tobias
What are common laboratory changes found 
with congenital PVH-MVD? 
Except for increases in bile acids, laboratory results 
for dogs with PVH-MVD may be completely normal. 
In fact, dogs with PVH-MVD usually have normal 
fasting bile acids, red cell size, BUN, protein, albumin, 
cholesterol, and Protein C concentrations. Their fed 
bile acids are often <70µmol/liter, and it is rare for them 
to have ammonium biurate crystals, 
bladder stones, or dilute urine. However, 
some dogs with PVH-MVD can be more 
severely affected, while some dogs with 
congenital portosystemic shunts that 
flow only intermittently can be mildly 
affected. Additionally, liver biopsy results 
are usually the same, so laboratory results 
alone cannot be used to diagnose either 
condition. 
What are bile acids?
Bile acids are produced in the liver and 
stored in the gallbladder between meals. 
When a dog eats a meal, particularly one 
with fat in it, the gall bladder contracts, 
and the bile acids are released into the 
intestines, where they help break down and absorb fats. 
Along with other nutrients and chemicals, bile acids are 
reabsorbed from the intestines and carried by the portal 
system back to the liver, where they are removed from 
the blood and stored again until they are needed. Dogs 
with liver disease such as inflammation, portosystemic 
shunts, or PVH-MVD have increased blood bile acid 
concentrations because the chemicals are not brought 
back to the liver by the blood (for instance, with a liver 
shunt), or the liver cells are unhealthy and therefore 
unable to remove the chemicals from the blood.
How is the bile acid test performed?      
Bile acids are measured after an overnight fast 
(“preprandial” or fasting bile acids) and then 2 hours 
after eating (“postprandial” or fed bile acids). Although 
fat is the most potent stimulator of gallbladder contraction 
and subsequent bile acid release, any type of food can be 
used. Therefore, the owners cannot blame high bile acids 
on the type of meal used.
Why are the fasting bile acids 
sometimes higher than the fed 
sample?
Usually bile acids are lowest after an 
overnight fast; these bile acids are called 
“preprandial” because they are measured 
before a meal. Two hours after a meal, 
bile acid concentrations are usually 
at their highest; these bile acids are 
“postprandial” because they are measured 
after eating. About 20% of dogs will have 
a gallbladder contraction in the middle 
of the night that will increase the first 
bile acid sample, making it essentially 
“postprandial”. This is why we measure 
2 samples. (Figure 2) If either sample is 
abnormal (above 15-20 micromoles/L, depending on 
the lab) the animal is considered to have some sort of 
liver disease. 
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“We do NOT expect normal dogs to have high bile 
acids. Owners may want to blame diet changes, stress, or 
other conditions for their dog’s high bile acids, but high 
bile acids only occur if there is liver disease.” 
—Tobias
How young can you test a patient for liver 
dysfunction by measuring bile acids?
No one really knows how early we can detect increased 
bile acids in dogs with congenital PSS or PVH-MVD. 
Liver function is considered to be normal by 8 weeks of 
age, and PSS have been diagnosed in dogs as early as 4 
weeks old. If bile acids are abnormal at 8 weeks of age, 
liver disease should be suspected, and the puppy’s blood 
should be retested at 12 weeks of age for abnormalities 
in bile acids and chemistries. Because congenital PSS 
and PVH-MVD are so common in certain breeds 
(e.g., Yorkies, Maltese, Cairn Terriers, Havanese, Irish 
Wolfhounds), susceptible breeds should have their bile 
acids and chemistries evaluated at 4 to 6 months of 
age for evidence of liver dysfunction. This will help the 
veterinarian develop an individualized health care plan 
for each pet and will alert the owners of the potential for 
future illnesses.
Do all dogs with PVH-MVD have increased 
bile acids?
Most affected dogs will have at least a small increase in 
one of their bile acids samples; however, in rare cases we 
have seen Yorkies with normal bile acids that have mild 
liver biopsy changes consistent with PVH-MVD.
Do all dogs with congenital PSS have 
increased bile acids?
Almost all dogs with PSS will have increased bile acids; 
however, congenital PSS have been reported in dogs 
with bile acids as low as 17 µmoles/L (normal, <20 
µmoles/L). It is likely these dogs have a shunt that gets 
compressed intermittently: for instance, one that runs 
along or through the diaphragm.
What techniques or handling requirements are 
used for the bile acid test?
Unlike ammonia and protein C measurements, no 
special techniques are required for handling and storage 
of serum for bile acid samples. The most important step 
is to separate the serum from the red cells. After that, 
the serum sample can be sent by regular mail or courier 
to a lab; it does not need to be refrigerated or frozen.
Can bile acids be used to diagnose PSS or 
PVH-MVD?
Most dogs with congenital PSS have high fasting and 
fed bile acids, while dogs with PVH-MVD usually have 
normal fasting and increased fed bile acids. Bile acids 
can increase with any liver disease, so high bile acids 
are not specific to congenital portosystemic shunts 
or PVH-MVD. To be certain a dog has a PSS or 
PVH-MVD, advanced imaging and liver biopsy 
are required.  That being said, if a Yorkie puppy 
presents with signs of hepatic encephalopathy, has 
ammonium biurate crystals, and has chemistry 
and CBC changes consistent with a shunt and its 
bile acids are over 100 micromoles/L, the most 
likely diagnosis is a congenital extrahepatic PSS. 
If a Yorkie has no clinical signs, normal urine 
and biochemistry results, and mildly increased 
postprandial bile acids, the most common cause 
is PVH-MVD.
Can abnormalities other than liver disease 
cause high bile acids?
About 95% of bile acids are reabsorbed through the 
intestines and sent to the portal system. That means 
that anything that causes decreased absorption (e.g., 
diarrhea or thickened intestines) can decrease bile acid 
concentrations and anything that increases absorption 
(e.g., inflammation or constipation) can increase bile 
acids. However, because a normal liver is so effective at 
removing bile acids from the bloodstream, we do NOT 
expect normal dogs to have high bile acids. Owners may 
want to blame diet changes, stress, or other conditions 
for their dog’s high bile acids, but high bile acids only 
occur if there is liver disease.    
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“Bile acid concentrations have not been 
correlated to the severity of liver disease  
(or shunting) and vary from day to day...”
—Tobias
...no special techniques 
are required for handling 
and storage of serum for 
bile acid samples.  
—Tobias
  
Can bile acids be used to monitor the 
dog’s status? 
Bile acid concentrations have not been correlated to 
the severity of liver disease (or shunting) and vary from 
day to day within the normal or the abnormal range. 
Obviously, bile acids of 300 micromoles/L are much 
worse than bile acids of 25 micromoles/L. However, 
many dogs may have bile acids of 40 one day and 80 the 
next. Because of differences in how much bile is being 
held within the gallbladder at one time, how much the 
gallbladder contracts, how fast the bile is moving through 
the intestines, and how much of it is being reabsorbed, 
we cannot say that the dog is worse when the bile acids 
are 80. We can only say that the bile acids are increased 
on both days and the liver is still not working properly. 
Why is this important? 
It means we need to use other methods to monitor how 
a dog with PVH-MVD or one that has undergone repair 
for a congenital shunt is doing long term. If your dog 
has PVH-MVD, we do not expect the bile acids to ever 
be normal (unless they were high for another reason). 
So, instead of measuring bile acids, we will look at the 
dog’s chemistries to make sure it can still make protein, 
albumin, BUN, and glucose and that its liver enzymes 
remain normal. That will give us much more information 
than changes in bile acids. 
Can protein C be used to differentiate shunts 
from PVH/MVD?
Protein C is a measure of an animal’s ability to stop clots 
from forming or to break them down. If you had a low 
protein C, you would be much more likely to develop 
clots in your legs during long plane flights. Like many 
clotting factors, protein C is made in the liver and is 
decreased with severe liver disease and PSS. Most dogs 
with PVH-MVD do not have severe liver disease, so they 
will  have normal protein C concentrations. Unfortunately, 
however, a few dogs do not follow these rules. Currently 
there is no blood test that is 100% accurate for 
differentiating shunts from PVH-MVD or other 
conditions. 
How do we differentiate congenital portal vein 
hypoplasia and congenital PSS? 
Many liver diseases can cause the same laboratory changes 
seen in dogs with congenital PSS or severe PVH-MVD. 
Therefore, to confirm the diagnosis, advanced imaging 
and liver biopsy are required. Shunts can be detected with 
trans-splenic scintigraphy, MRI, or a CT (“Cat” scan) or 
by an experienced ultrasonographer. If no shunting is 
found on these tests, a liver biopsy is obtained to confirm 
the diagnosis of PVH-MVD and rule out other liver 
diseases caused by inflammation, infection, or 
toxins. If no shunting is seen on CT or scintigraphy 
and the liver biopsy is positive for MVD, then the 
dog has PVH-MVD. Alternatively, an experienced 
surgeon may elect to explore the abdomen to look 
for a shunt and to obtain liver biopsies. If no shunt 
is found, a portogram (contrast x-ray study of the 
blood vessels) can be performed during surgery. 
The final x-ray, or “portogram”, highlights all the 
vessels to the liver and any shunting vessels carrying 
blood around it.
Differential Diagnoses
The term “differential diagnosis” refers to conditions  that 
cause similar signs or blood work changes. For instance, 
any liver disease could cause the blood work changes 
seen in dogs with congenital PSS, including increases 
in ammonia and bile acids and decrease in Protein C. 
Besides liver disease, formation of ammonium biurate 
crystals and urate stones can occur with certain metabolic 
conditions; these are particularly common in Dalmatians. 
Hepatic encephalopathy must be differentiated from 
distemper, hydrocephalus, hypoglycemia, toxicities, and 
epilepsy and even behavior changes.
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 If bile acids are abnormal at 8 weeks of age, liver disease should be suspected, 
and the puppy’s blood should be retested at 12 weeks of age for abnormalities 
in bile acids and chemistries. Because congenital PSS and PVH-MVD are so 
common in Yorkies...bile acids and chemistries should be evaluated at 4 to 6 
months of age for evidence of liver dysfunction. This will help the veterinarian 
develop an individualized health care plan for each pet and will alert the 




What is a Portogram?
What is a CT Scan?
“If no shunting is seen on CT or scintigraphy and the liver biopsy is 
positive for MVD, then the dog has PVH-MVD.”
—Tobias
Scintigraphy is a nuclear scan that measures blood flow. To evaluate a 
dog for a shunt, a radioactive material is inserted into the colon (by a 
high enema) or injected into the spleen (“trans-splenic” scintigraphy), 
and a special camera is used to measure the amount of radioactivity in 
the dog’s heart and liver. Trans-splenic scintigraphy produces a better 
image and uses less radioactive material, so it is preferred over colonic 
scintigraphy. In a normal dog, over 95% of the radioactive material 
injected into the spleen will head to the liver; if more than 5% goes to 
the heart, a shunt is diagnosed. Scintigraphy is safe and quick but does 
require heavy sedation or anesthesia. Small dogs can often be released 
from the hospital on the same day of trans-splenic scintigraphy, but 
larger dogs and those with multiple acquired shunts usually need to stay 
overnight until they have expelled the radioactive material by defecation 
and urination. Scintigraphy tells us that shunting is present and often 
lets us know if the shunts are congenital or acquired, but it does not tell 
us whether the shunt is inside or outside of the liver. 
A portogram is an X-ray of the blood vessels to the liver. Because blood 
vessels are not easily seen on regular x-rays, a contrast material (a liquid 
that looks white on X-rays) must be injected into a blood vessel in the 
abdomen. The injection can be performed through a surgical incision 
into the belly; by injecting the spleen directly through the skin; or by 
passing a catheter down the jugular vein (in the neck), through the 
heart, and toward the abdomen. Portograms usually require anesthesia 
and are more invasive than scintigraphy or CT scans. They are usually 
quite safe, however, and are able to provide a picture of the PSS so that 
the veterinarian can see where it is located and whether there is more 
than one. Many board certified surgeons have an X-ray machine, called 
a C-arm, in their operating rooms, which allows them to quickly and 
safely perform a portogram during surgery.
Computed tomography, known as CT or “CaT” scan, is a technique 
that provides multiple cross-sectional X-rays of bones and organs. 
CT scans are usually performed under anesthesia.  In a dog with 
a PSS, a CT can be used to make the diagnosis of a shunt and to 
determine the specific location of the shunt. This makes surgical 
intervention easier, particularly when the shunt is hidden inside 
the liver. Preoperative CT scans are often performed on large breed 
dogs because they usually have intrahepatic shunts. 
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If a Yorkie has no clinical signs, 
normal urine and biochemistry 
results, and mildly increased 
postprandial bile acids, the most 
common cause is PVH-MVD.
—Tobias
“To be certain a dog has PVH-MVD, advanced imaging and 
liver biopsy are required.”
—Tobias
Liver Biopsy
Liver biopsy can be obtained by open surgical 
technique (“laparotomy”) or by laparoscopy (use of a 
scope). (Figure 3) Ultrasound-guided needle biopsies 
are not recommended because small liver size in dogs 
with congenital PSS and PVH-MVD increases the risk 
of complications, and because the small sample size 
obtained by needle makes diagnosis of MVD difficult. 
Some clinicians recommend taking samples from 
multiple liver lobes, since the amount of disease could 
differ from lobe to lobe. (Figure 4)
Figure 4. Micrograph taken of a slide from a liver biopsy specimen 
revealing the classical pathology of PVH-MVD.
Figure 3. Photograph of the two small incisions made from a 
laparoscopic spay and biopsy.
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Medical and Nutritional Management
“...protein restricted instead of low protein...is 
important, because animals with liver disease that 
receive too little protein will break down their own 
muscle tissue to make more.”  
—Tobias
What medical management is recommended for 
dogs with congenital PSS?
Diet
Most of the toxins that cause problems in dogs with 
congenital PSS come from proteins broken down 
by bacteria in the colon. Therefore, the most 
important treatment of dogs with congenital PSS 
is an appropriate diet. Commercial liver diets 
such as Hill’s Prescription Diet l/d Canine Hepatic 
Health and Royal Canin Veterinary Diet Hepatic 
Formula provide quality proteins that are readily 
digestible in the small intestine so that minimal 
amounts reach the colonic bacteria. These diets 
have protein concentrations that are higher than 
those in many of the kidney diets; in fact, they are 
considered “protein restricted” instead of “low protein”. 
This is important, because animals with liver disease 
that receive too little protein will break down their own 
muscle tissue to make more.  
Probiotics
Some dogs may benefit from the addition of yogurt with 
active cultures to their diet. For example, 2.2 ounces of 
Activa vanilla yogurt can be added to each 1000 kcals 
of food. That is roughly 1-2 tsp of yogurt once or twice 
a day for a small Yorkie. This type of “probiotic” has 
been shown to reduce signs of hepatic encephalopathy 
in people, and the yogurt also provides another source 
of high quality, readily digestible protein.
Lactulose
Lactulose syrup is a double sugar that is broken 
down by bacteria in the colon to two simple sugars. 
This reaction is beneficial in several ways. First, the 
reaction produces an acidic environment that may be 
unattractive to troublesome bacteria and that reduces 
ammonia absorption. Second, the resulting sugars 
cause absorption of fluid into the feces, which makes 
them move out faster. Because of this second effect, 
lactulose must be dosed carefully: too much could result 
in diarrhea. In general, owners should give a dose that 
results in 2 to 3 soft-but-formed stools per day. For most 
Yorkshire terriers, that means 2 mls by mouth 2 to 3 
times each day. The dose should be decreased if diarrhea 
or cow pie stools develop, and increased for constipated 
dogs.
Antibiotics 
Antibiotics are prescribed for animals with active 
infections (for instance, urinary tract infections) or 
those with neurologic signs. Certain antibiotics will kill 
off the bacteria in the colon that are causing ammonia 
production. Antibiotics are not used routinely, however, 
because of potential side effects. 
Supplements
Some veterinarians will prescribe supplements that reduce 
inflammation of the liver, such as denosyl (“SAM-E”) 
and silymarin (milk thistle). While these supplements 
can be purchased over the counter, their content and 
manufacturing are not regulated by the FDA. Therefore, 
use of veterinary products is recommended, since these 
have been appropriately tested for active ingredients. 
Denamarin (Nutramax Laboratories) is a common brand; 
the chewable form is preferred because it has greater 
absorption and causes less stomach upset. Use of these 
nutriceuticals in dogs with congenital PSS or PVH-MVD 
has not been studied, so no one knows whether they make 
any difference in these dogs. Owners should never give 
any supplements that could have negative effects on their 
pet’s liver, nor should they use any chemical products 
around their house that have risks of toxicity.
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“Dogs with PVH-MVD that have clinical signs...
can be medically managed just like dogs with 
congenital PSS. Most critical is the use of a  
protein-restricted diet.”
—Tobias
effect”, which commonly happens when owners 
give their animals treatments. The owners believe 
it will work and therefore see positive changes in 
their dogs, even if those changes are not really 
caused by the treatment. A more scientific method 
for monitoring response to therapy in dogs that 
have abnormalities in their blood chemistries or 
ammonia is to monitor these blood chemicals for 
changes when treatment is started or stopped. 
For dogs with high blood ammonia, the ammonia 
concentration should drop to normal levels 
when appropriate treatment is given. 
Information on preparing homemade diets
Homemade diets formulated by veterinary 
nutritionists can be used for dogs that have 
congenital PSS or PVH-MVD. An example can 
be seen at: http://www.vet.utk.edu/clinical/sacs/
shunt/pdf/GenericLiverShuntDiet.pdf.  There is 
some risk to use of a homemade diet because changes 
in the diet content can make it unbalanced. This 
most often occurs when an owner decides to change 
the ingredients, but it can also occur if the quality of 
the dietary components change. For instance, diets 
that include chicken breast will have a different fat 
and calorie content than those made with the darker, 
thigh meat. Over several months, this could lead to 
nutritional deficits. If you are interested in feeding a 
homemade diet, you will need to work closely with 
your veterinarian or a veterinary nutritionist to 
make a diet that is complete, balanced, and healthy 
for your pet. Information about nutrition consults 
can be found at: http://www.vet.utk.edu/clinical/
sacs/nutrition.php.
How is a dog diagnosed with PVH-MVD that 
has clinical signs treated? 
Dogs with PVH/MVD that have clinical signs, 
ammonium biurate crystals, or abnormal blood 
chemistries (for instance, high liver enzymes, low 
protein, low albumin) can be medically managed 
just like dogs with congenital PSS. Most critical is 
the use of a protein-restricted diet.
What about dogs with PVH-MVD that are 
“asymptomatic” and have normal chemistries?  
There are no studies on medical management of 
dogs with PVH-MVD that only have increased bile 
acids. Therefore, we have no idea whether affected 
dogs have a shortened lifespan and whether medical 
management makes any difference. 
Don’t bother to ask whether lactulose, diet, yogurt, 
SAM-e, milk thistle, antibiotics, or anything else 
will be helpful to your ‘asymptomatic’ dog; the fact 
is, nobody knows! All we can tell you is that many of 
our “normal” Yorkie patients have mildly increased 
bile acids and live long lives, as long as they don’t get 
sick from something else. 
Response to therapy explained
One option for owners of  dogs with PVH-MVD is to 
base the need for medical management on “response 
to therapy”. In simple terms, “response to therapy” 
is what happens to the animals when a treatment is 
started or stopped. In other words, if dietary change 
or administration of medications makes the animal 
feel worse, the treatment should be discontinued; if it 
makes the animal feel better, it should be continued. 
One problem with a positive response is a “placebo 
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“...because systemic illness may hit them harder than dogs with normal 
livers, it’s important to continue any 
recommended preventatives.”
—Tobias
What is the prognosis for dogs diagnosed with 
congenital PVH-MVD?
We can comfortably say that dogs with mild increases 
in bile acids and no other evidence of liver disease 
or clinical signs may live normal lifespans. In fact, 
most Yorkie owners never know their dogs have 
PVH-MVD because they never test for it. Based 
on a routine survey of bile acids from 139 healthy 
Yorkies, we suspect that over half of all Yorkies have 
this condition. Perhaps we have even bred for 
it by selecting for smaller and smaller dogs. So 
what about the dogs that have clinical signs? 
We know that dogs with PVH-MVD that are 
presented because of illness can and do respond 
to medical management. We also know that 
many of these dogs will live for years when kept 
on an appropriate diet. In most cases, dogs with 
PVH-MVD succumb from other conditions, 
including old age. Rarely, the condition will 
progress to liver failure. That is why yearly or twice 
yearly check-ups are recommended.
What is the prognosis for dogs diagnosed with 
congenital PSS that are only treated medically?
About 50% of dogs with congenital PSS will live long 
lives if they are medically managed appropriately and 
they don’t get other illnesses. These are usually the dogs 
that are less severely affected based on their clinical signs 
and blood work. The outcome is much better for dogs 
with extrahepatic congenital PSS that undergo surgical 
closure with an ameroid constrictor or cellophane 
band. In fact, 85% to 90% of these dogs do well long 
term. Surgery does have risks, however, and about 5% 
of the dogs may die after the procedure because of 
seizures or pneumonia. Yorkies 
that undergo surgery will almost 
always have mildly increased 
bile acids the rest of their lives. 
This is because they usually also 
have PVH-MVD, which is not 
cured by surgery.
What type of rechecks are recommended for 
dogs with PVH-MVD?
Blood chemistries and ammonia, if available, can be 
rechecked every 6 to 12 months to make sure that the 
dog is producing a sufficient amount of proteins and 
no signs of inflammation or organ failure are present. 
Bile acids do not need to be rechecked—they do not 
correlate well with the amount of liver damage and will 
only cause unnecessary worry for owners. 
Can dogs with congenital PVH-MVD receive 
vaccinations and flea and tick preventatives?
Because dogs with PVH-MVD are susceptible to all 
the usual parasites and viruses, and because systemic 
illness may hit them harder than dogs with normal 
livers, it’s important to continue any recommended 
preventatives. Heartworm, flea, and tick preventatives 
and vaccines should be given as usual. If owners 
are concerned about the stress vaccinations may 
place on their pet, they can ask their veterinarian 
to develop a schedule so that administration of 
individual vaccines is separated by at least a few 
weeks. Preventative care  is also safe and highly 
recommended for dogs with congenital PSS, whether 
or not the shunts have been repaired.
Can vaccinations cause PVH-MVD?
PVH-MVD is not caused by vaccines because it is a 
congenital disease. It is important to continue routine 
vaccinations and preventatives in these dogs so they do 
not get other conditions that can make them ill.
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Genetics, Risk & Breeding
“Until a genetic test is available or the trigger for 
the condition is determined, it would be prudent 
to breed only dogs with the healthiest livers...Dogs 
with congenital PSS should not be bred.”  —Tobias
Based on Dr. Center’s work, it may not be possible to 
have a genetic test that differentiates congenital PSS 
from PVH-MVD. In fact, they may simply represent 
variations of the same genetic conditions. We can also 
see that the risk of having the genes for either condition 
is very high in Yorkies and other toy breeds.
What happens if you breed a dog with 
congenital PVH-MVD?
A very difficult question to answer is whether dogs 
with PVH-MVD should be bred. Based on results of 
breed analysis, PVH-MVD is an inherited condition. 
Congenital shunts are also considered hereditary in 
many breeds. It makes sense, therefore, that we should 
avoid breeding any dogs that have increased bile acids or 
other signs of liver disease. However, we can see from Dr. 
Center’s work that many apparently healthy Yorkies carry 
these genes. Until a genetic test is available or the trigger 
for the condition is determined, it would be prudent to 
breed only dogs with the healthiest livers and to reduce 
inbreeding of affected dogs. Dogs with congenital PSS 
should not be bred. A reproductive specialist should be 
consulted for more information.
What is the genetic research regarding 
congenital PVH-MVD?
Dr. Sharon Center, a professor of small animal 
internal medicine at Cornell’s College of Veterinary 
Medicine, is the principal investigator of a 
research study funded through Morris Animal 
Foundation called “Genetics of Portosystemic 
Vascular Anomalies & Microvascular Dysplasia 
in Small Breed Dogs.” Here is a quote from her 
last progress update:
“Since the last report, researchers have 
expanded their genetic analysis to include 
a larger population of Cairn and Yorkshire 
Terriers afflicted with PSVA [congenital 
PSS] or MVD [PVH-MVD]. Cairn Terriers 
are representative of breeds like Tibetan spaniels 
and Miniature Schnauzers with lower genetic 
trait prevalence (approximately 30 to 35%); 
Yorkshire Terriers are representative of breeds 
like Norfolk Terriers, Maltese, Havanese and 
Papillion with higher genetic trait prevalence 
(approximately 65 to 90%). Once genetic 
mutations responsible for PSVA and MVD are 
identified, the investigators plan to develop 
genetic tests that can identify carrier animals. 
These tests could be used to make breeding 
decisions which could reduce and eventually 
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